Target intelligence / Profile preview

Ribosomal protein L34 pseudogene 6 (RPL34P6)

Target
RPL34P6
Molecular classification
Other (Pseudogene)
01

Overview

RPL34P6 (ribosomal protein L34 pseudogene 6) is a processed pseudogene in the human genome, officially approved by HGNC as HGNC:35810. Pseudogenes are DNA segments that resemble functional genes but are generally nonfunctional due to mutations or absence of regulatory elements. RPL34P6 is related to the ribosomal protein L34 (which is a protein-coding gene and a component of the large ribosomal 60S subunit), but RPL34P6 itself does not encode a protein and thus does not play a direct physiological, pharmacological, or disease-associated role. Pseudogenes are typically classified as "other" in molecular classification schemes, distinguishing them from protein-coding genes such as enzymes, receptors, or transporters.

Other names
RPL34P6RPL34_4_146Ribosomal protein L34 pseudogene 6
02

Mechanism of action

None; pseudogene does not encode a functional product.

03

Biological functions

None directly; as a pseudogene, it does not encode a functional protein
04

Disease associations

None directly; as a pseudogene, it is not known to be directly involved in disease.Ribosomal protein L34 (not this pseudogene) has roles in cancer when overexpressed, but RPL34P6 itself is not implicated.
05

Safety considerations

None; not a therapeutic target.
06

Interacting drugs

None; no drugs known to interact with this pseudogene.
07

Biomarkers

None; pseudogene is not used as a biomarker.

Beyond the preview

Go deeper on Ribosomal protein L34 pseudogene 6 (RPL34P6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L34 pseudogene 6 (RPL34P6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call